Eylea Post Marketing Surveillance(PMS)

Sponsor
Bayer
Study ID
NCT01783925
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The objective of this PMS is to gain information about safety and efficacy in real practice as a regulatory commitment required by MFDS

Key Dates

Start date
Apr 29, 2014
Status verified
Nov 2023
Primary completion
Dec 31, 2018
Completion
Dec 31, 2018

Study Design

Enrollment
3,206 participants (actual)

Arms

  • Arm: Group 1

Primary Outcome Measure

Adverse events (AEs) [including serious adverse events (SAEs) and ocular AEs, especially AEs due to intravitreal injection procedure] and adverse drug reactions (ADRs) [ Time Frame: 4 months ]

Related Studies